Yen-Zhen Lu1, Ching-Ying Huang1, Yi-Cheng Huang1, Tsung-Chun Lee1,2, Wei-Ting Kuo1, Yu-Chen Pai1, Linda Chia-Hui Yu3. 1. Graduate Institute of Physiology, National Taiwan University College of Medicine, Suite 1020, #1 Jen-Ai Rd. Sec. I, Taipei 100, Taiwan, ROC. 2. Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROC. 3. Graduate Institute of Physiology, National Taiwan University College of Medicine, Suite 1020, #1 Jen-Ai Rd. Sec. I, Taipei 100, Taiwan, ROC. lchyu@ntu.edu.tw.
Abstract
BACKGROUND: Intestinal ischemia/reperfusion (I/R) causes barrier impairment and bacterial influx. Protection against I/R injury in sterile organs by hypoxic preconditioning (HPC) had been attributed to erythropoietic and angiogenic responses. Our previous study showed attenuation of intestinal I/R injury by HPC for 21 days in a neutrophil-dependent manner. AIM: To investigate the underlying mechanisms of neutrophil priming by HPC, and explore whether adoptive transfer of primed neutrophils is sufficient to ameliorate intestinal I/R injury. METHODS: Rats raised in normoxia (NM) and HPC for 3 or 7 days were subjected to sham operation or superior mesenteric artery occlusion for I/R challenge. Neutrophils isolated from rats raised in NM or HPC for 21 days were intravenously injected into naïve controls prior to I/R. RESULTS: Similar to the protective effect of HPC-21d, I/R-induced mucosal damage was attenuated by HPC-7d but not by HPC-3d. Naïve rats reconstituted with neutrophils of HPC-21d rats showed increase in intestinal phagocytic infiltration and myeloperoxidase activity, and barrier protection against I/R insult. Elevated free radical production, and higher bactericidal and phagocytic activity were observed in HPC neutrophils compared to NM controls. Moreover, increased serum levels of tumor necrosis factor α (TNFα) and cytokine-induced neutrophil chemoattractant-1 (CINC-1) were seen in HPC rats. Naïve neutrophils incubated with HPC serum or recombinant TNFα, but not CINC-1, exhibited heightened respiratory burst and bactericidal activity. Lastly, neutrophil priming effect was abolished by neutralization of TNFα in HPC serum. CONCLUSIONS: TNFα-primed neutrophils by HPC act as effectors cells for enhancing barrier integrity under gut ischemia.
BACKGROUND: Intestinal ischemia/reperfusion (I/R) causes barrier impairment and bacterial influx. Protection against I/R injury in sterile organs by hypoxic preconditioning (HPC) had been attributed to erythropoietic and angiogenic responses. Our previous study showed attenuation of intestinal I/R injury by HPC for 21 days in a neutrophil-dependent manner. AIM: To investigate the underlying mechanisms of neutrophil priming by HPC, and explore whether adoptive transfer of primed neutrophils is sufficient to ameliorate intestinal I/R injury. METHODS:Rats raised in normoxia (NM) and HPC for 3 or 7 days were subjected to sham operation or superior mesenteric artery occlusion for I/R challenge. Neutrophils isolated from rats raised in NM or HPC for 21 days were intravenously injected into naïve controls prior to I/R. RESULTS: Similar to the protective effect of HPC-21d, I/R-induced mucosal damage was attenuated by HPC-7d but not by HPC-3d. Naïve rats reconstituted with neutrophils of HPC-21d rats showed increase in intestinal phagocytic infiltration and myeloperoxidase activity, and barrier protection against I/R insult. Elevated free radical production, and higher bactericidal and phagocytic activity were observed in HPC neutrophils compared to NM controls. Moreover, increased serum levels of tumor necrosis factor α (TNFα) and cytokine-induced neutrophil chemoattractant-1 (CINC-1) were seen in HPC rats. Naïve neutrophils incubated with HPC serum or recombinant TNFα, but not CINC-1, exhibited heightened respiratory burst and bactericidal activity. Lastly, neutrophil priming effect was abolished by neutralization of TNFα in HPC serum. CONCLUSIONS: TNFα-primed neutrophils by HPC act as effectors cells for enhancing barrier integrity under gut ischemia.
Authors: Wanja M Bernhardt; Valentina Câmpean; Sarah Kany; Jan-Steffen Jürgensen; Alexander Weidemann; Christina Warnecke; Michael Arend; Stephen Klaus; Volkmar Günzler; Kerstin Amann; Carsten Willam; Michael S Wiesener; Kai-Uwe Eckardt Journal: J Am Soc Nephrol Date: 2006-06-08 Impact factor: 10.121
Authors: F A Rodríguez; J L Ventura; M Casas; H Casas; T Pagés; R Rama; A Ricart; L Palacios; G Viscor Journal: Eur J Appl Physiol Date: 2000-06 Impact factor: 3.078
Authors: Donnie E Shifflett; Frank G Bottone; Karen M Young; Adam J Moeser; Samuel L Jones; Anthony T Blikslager Journal: Am J Physiol Gastrointest Liver Physiol Date: 2004-03-11 Impact factor: 4.052
Authors: Diane I Bitzinger; Felix Schlachetzki; Regina Lindner; Benedikt Trabold; Michael S Dittmar Journal: Cytometry A Date: 2008-07 Impact factor: 4.355
Authors: Xin Fan; Juan Du; Mao-Hua Wang; Jia-Man Li; Bo Yang; Ye Chen; Jun-Chao Dai; Chunxiang Zhang; Jun Zhou Journal: Oxid Med Cell Longev Date: 2019-05-02 Impact factor: 6.543